Close Menu

NEW YORK (360Dx) — RenalytixAI said today that it has partnered with the University Medical Center Groningen (UMCG) in the Netherlands to evaluate its KidneyIntelX kidney disease test in a 3,500-patient clinical study.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.